Experimental & Molecular Medicine, Published online: 09 November 2026; doi:10.1038/s12276-026-01883-0 Bone metastasis is a significant complication of breast cancer, severely impacting patients' quality of life and survival. This study explores the roles of SMAD1–RUNX2 and SMAD2/3–RUNX2 complexes in breast cancer bone metastasis. Researchers used breast cancer cells with wild-type or mutated RUNX2 to analyze the effects of these complexes under TGFβ and BMP treatments. They found that SMAD2/3–RUNX2 promotes cancer cell migration to bone, while SMAD1–RUNX2 enhances cell adhesion to bone. These complexes differentially regulate gene expression related to metastasis, with SMAD2/3–RUNX2 facilita
Rong Meng, Jia-Ni Fang, Jie Zhou, Xiao-Qing Li. Dynamic SMAD–RUNX2 complexes orchestrate breast cancer bone metastasis. // Experimental & Molecular Medicine. – 2026. – DOI: 10.1038/s12276-026-01883-0. – URL: https://www.nature.com/articles/s12276-026-01883-0
Rong Meng, Jia-Ni Fang, Jie Zhou, & Xiao-Qing Li (2026). Dynamic SMAD–RUNX2 complexes orchestrate breast cancer bone metastasis. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01883-0
Rong Meng, et al. “Dynamic SMAD–RUNX2 complexes orchestrate breast cancer bone metastasis.” Experimental & Molecular Medicine, 2026. doi:10.1038/s12276-026-01883-0.
@article{Meng2026,
title = {Dynamic SMAD–RUNX2 complexes orchestrate breast cancer bone metastasis},
author = {Meng, Rong and Fang, Jia-Ni and Zhou, Jie and Li, Xiao-Qing},
journal = {Experimental \& Molecular Medicine},
year = {2026},
doi = {10.1038/s12276-026-01883-0},
url = {https://www.nature.com/articles/s12276-026-01883-0}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’